<SEC-DOCUMENT>0001437749-21-002024.txt : 20210204
<SEC-HEADER>0001437749-21-002024.hdr.sgml : 20210204
<ACCEPTANCE-DATETIME>20210204172545
ACCESSION NUMBER:		0001437749-21-002024
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210129
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210204
DATE AS OF CHANGE:		20210204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Proto Labs Inc
		CENTRAL INDEX KEY:			0001443669
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED STRUCTURAL METAL PRODUCTS [3440]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35435
		FILM NUMBER:		21592372

	BUSINESS ADDRESS:	
		STREET 1:		5540 Pioneer Creek
		CITY:			Maple Plain
		STATE:			MN
		ZIP:			55359
		BUSINESS PHONE:		763-479-7474

	MAIL ADDRESS:	
		STREET 1:		5540 Pioneer Creek
		CITY:			Maple Plain
		STATE:			MN
		ZIP:			55359
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>prlb20210203_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:prlb="http://www.prlb.com/20210129"><head>
	<title>prlb20210203_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 2/4/2021 10:18:24 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20218K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20218K" name="dei:EntityCentralIndexKey">0001443669</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="prlb-20210129.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20218K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001443669</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-01-29</xbrli:startDate>
<xbrli:endDate>2021-01-29</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>UNITED STATES</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Washington, D.C. 20549</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>FORM <ix:nonNumeric contextRef="d20218K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT<br />
PURSUANT TO SECTION 13 OR 15(d) OF THE<br />
SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 46.2%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 26.9%; margin-right: 26.9%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>January 29</b><b>, 2021</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of report (Date of earliest event reported)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 75.8%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12.1%; margin-right: 12.1%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center; text-transform: uppercase;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityRegistrantName"><b>PROTO LABS, INC.</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact Name of Registrant as Specified in its Charter)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:99.8%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Minnesota</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:3.7%;">&#xa0;</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityFileNumber"><b>001-35435</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:3.8%;">&#xa0;</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityTaxIdentificationNumber"><b>41-1939628</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State of Incorporation)</div>
			</td>
			<td style="vertical-align:top;width:3.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:3.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:30.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:46.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressAddressLine1"><b>5540 </b><b>Pioneer Creek Drive</b></ix:nonNumeric><br />
			<ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressCityOrTown"><b>Maple Plain</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>Minnesota</b></ix:nonNumeric></b></div>
			</td>
			<td colspan="3" style="vertical-align:bottom;width:22.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:31.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressPostalZipCode"><b>55359</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:46.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of Principal Executive Offices)</div>
			</td>
			<td colspan="3" style="vertical-align:top;width:22.3%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Zip Code)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:46.6%;">&#xa0;</td>
			<td colspan="3" style="vertical-align:top;width:22.3%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.1%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align:top;border-bottom:solid 1px #000000;;width:54.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(<ix:nonNumeric contextRef="d20218K" name="dei:CityAreaCode"><b>763</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20218K" name="dei:LocalPhoneNumber"><b>479-3680</b></ix:nonNumeric></b></div>
			</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align:top;width:54.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Registrant&#8217;s Telephone Number, Including Area Code)</div>
			</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align:top;width:54.6%;">&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;border-bottom:solid 1px #000000;;width:57.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Not Applicable</b></div>
			</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:57.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Former Name or Former Address, if Changed Since Last Report)</div>
			</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="margin-left: 0.1%; width: 99.9%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border: 1px solid black;">

		<tbody><tr>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:37.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Title of each class</div>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 25.2%; border-left: thin solid rgb(0, 0, 0); border-right: thin solid rgb(0, 0, 0);">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Trading Symbol(s)</div>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:37.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 37.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, Par Value $0.001 Per Share</div>
			</td>
			<td style="vertical-align: top; width: 25.2%; border-left: thin solid rgb(0, 0, 0); border-right: thin solid rgb(0, 0, 0);">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:TradingSymbol">PRLB</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 37.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric>&#xa0;&#xa0;&#xa0;&#xa0;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric>&#xa0;&#xa0;&#xa0;&#xa0;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric>&#xa0;&#xa0;&#xa0;&#xa0;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric>&#xa0;&#xa0;&#xa0; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;">Emerging growth company <ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 5.0</b><b>2</b><b>. </b><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b><b>.</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#xa0;</b></div>

<div style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><span style="text-decoration: underline;">Robert Bodor Executive Employment Agreement</span></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On January 29, 2021, Proto Labs, Inc. (the &#8220;Company&#8221;) entered into an Executive Employment Agreement, with Robert Bodor, effective as of March 1, 2021 (the &#8220;Employment Agreement&#8221;). As previously announced, Dr. Bodor will replace Victoria M. Holt as President and Chief Executive Officer of the Company. The Board of Directors (the &#8220;Board&#8221;) also elected Dr. Bodor as a director of the Board, effective upon the assumption of his role as President and Chief Executive Officer.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Since January 2015, Dr. Bodor, 48, has served as Vice President/General Manager &#8211; Americas of the Company, and will continue to serve in such role until he assumes his new position as President and Chief Executive Officer. Dr. Bodor also served as the Chief Technology Officer of the Company from July 2013 to January 2015. Dr. Bodor started at the Company in 2012 as Director of Business Development. Prior to joining the Company in 2012, Dr. Bodor held several roles at Honeywell, most recently leading SaaS business offerings for Honeywell&#8217;s Life Safety Division. He also spent 4 years with McKinsey &amp; Company.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company entered into the Employment Agreement with Dr. Bodor in recognition of the need to provide him certain protection as President and Chief Executive Officer should his employment with the Company be involuntarily terminated without cause or terminated by him for good reason before or after a change in control of the Company, as those terms are defined in the Employment Agreement. Dr. Bodor&#8217;s employment with the Company is at-will and his employment may be unilaterally terminated by Dr. Bodor or the Company at any time for any reason, subject to the terms of the Employment Agreement.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pursuant to the Employment Agreement, Dr. Bodor will receive an initial annual base salary of $500,000 and will be eligible for an annual target cash incentive bonus payment equal to 100% of his annual base salary.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Dr. Bodor will receive an additional equity grant pursuant to the Company&#8217;s 2012 Long-Term Incentive Plan, 50% in the form of stock options and 50% in the form of restricted stock units, with an aggregate fair market value of $1.3 million (as measured on the date of grant and based on the Board&#8217;s assessment of the Company's performance against Dr Bodor&#8217;s and the Company's performance objectives). The grant date (the &#8220;Grant Date&#8221;) for this new equity grant will be the earliest day permitted pursuant to the terms of the Company&#8217;s Equity Award Approval Policy following commencement of Dr. Bodor&#8217;s assumption of his new position as President and Chief Executive Officer.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Dr. Bodor will also be eligible for an annual equity grant on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company. Dr. Bodor&#8217;s annual equity grant in 2022 is expected to be 50% in the form of performance stock units, 30% in the form of restricted stock units, and 20% in the form of stock options. It is expected that Dr Bodor&#8217;s equity grants received in 2021 will have an aggregate grant date fair value of approximately $2.0 million.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If the Company voluntarily terminates Dr. Bodor&#8217;s employment without cause (and other than as a result of his death or disability) or if he resigns for good reason, provided that Dr. Bodor complies with certain conditions (including execution of a general waiver and release of claims in favor of the Company), then he will be entitled to certain benefits pursuant to the Employment Agreement. If Dr. Bodor&#8217;s employment with the Company terminates during the term of the Employment Agreement, and if the termination is without cause (other than as a result of death or disability) or for good reason (a &#8220;Qualifying Termination&#8221;), and the Qualifying Termination is prior to any change in control or after the Transition Period (as defined below), then, subject to certain conditions:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">the Company will pay Dr. Bodor an amount equal to one times his annualized base salary in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 12-month period immediately following the termination date, subject to limited exceptions;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">the Company will pay Dr. Bodor an amount equal to one times his target annual cash incentive bonus for the calendar year in which his employment with the Company terminates, payable in a lump sum;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">if Dr. Bodor was enrolled in a group health plan sponsored by the Company immediately prior to his employment termination, then the Company will pay its share of premiums due for Dr. Bodor and his eligible dependents to continue such coverage under Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;) for the first 12 months of COBRA coverage, if elected by Dr. Bodor; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">if Dr. Bodor has any unvested equity-based awards as of the termination date, a pro rata portion of any time-based unvested awards scheduled to vest on the next anniversary of the grant date will vest immediately based on the number of such equity-based awards that would have vested as of the next anniversary assuming Dr. Bodor&#xa0;would have remained employed through the anniversary, pro-rated based on the number of days Dr. Bodor was employed by the Company during the then-current vesting year divided by the number of days in a year.&#xa0;For performance-based awards, the number of additional shares that will vest as a result of such pro rata vesting will be determined by multiplying the total number of additional shares that would otherwise have been determined to have been earned had Dr. Bodor&#xa0;remained employed through the end of the applicable performance period by a fraction, the numerator of which is the number of days Dr. Bodor was employed by the Company during the performance period and the denominator of which is the number of days in the performance period.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If Dr. Bodor&#8217;s termination date occurs during the term of the Employment Agreement and within 90 days prior to a change in control, and if the termination is a Qualifying Termination and Dr. Bodor reasonably demonstrates within 30 days after the change in control that the Qualifying Termination arose in connection with or in anticipation of the change in control, then the Company will pay Dr. Bodor the following amounts in addition to the amounts described above as to be paid in connection with a Qualifying Termination:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">an amount equal to one times his annualized base salary, payable in a lump sum;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">an amount equal to one times his target annual cash incentive bonus for the calendar year in which his employment with the Company terminates, payable in a lump sum;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company&#8217;s share of premiums due for Dr. Bodor and his eligible dependents for an additional six months of coverage under COBRA (after the initial 12-month COBRA coverage period ends), if elected by Dr. Bodor; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">an amount equal to the value of any unvested equity-based awards held by him as of the termination date that were forfeited as of the termination date.&#xa0;In the case of forfeited performance-based awards, the intrinsic value shall be based on the number of shares subject to an award based on a determination by the Board of the degree to which any performance-based vesting or payment conditions will be deemed satisfied.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If a change in control occurs during the term of the Employment Agreement and Dr. Bodor&#8217;s termination date occurs within the18-month period following the change in control (the &#8220;Transition Period&#8221;), and if the termination is a Qualifying Termination, then, subject certain conditions:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">the Company will pay Dr. Bodor an amount equal to two times his annualized base salary in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 24-month period immediately following the termination date, subject to limited exceptions;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">the Company will pay Dr. Bodor an amount equal to two times his target annual cash incentive bonus for the calendar year in which his employment with the Company terminates, payable in a lump sum;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If Dr. Bodor was enrolled in a group health plan sponsored by the Company immediately prior to his employment termination, then the Company will pay its share of premiums due for Dr. Bodor and his eligible dependents to continue such coverage under COBRA for the first 18 months of COBRA coverage, if elected by Dr. Bodor; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9679;</div>
			</td>
			<td>
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">if Dr. Bodor has any unvested equity-based awards as of the termination date, all such unvested awards will vest immediately on Dr. Bodor&#8217;s termination date.&#xa0;In the case of performance-based awards, the number of shares subject to such accelerated vesting shall be based on a determination by the Board&#xa0;of the degree to which any performance-based vesting conditions will be deemed satisfied.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If Dr. Bodor&#8217;s employment with the Company is terminated due to his death or disability (as defined in the Employment Agreement), then, in addition to payment of accrued but unpaid salary and benefits, Dr. Bodor (or his estate) will be entitled to receive a pro rata portion of his target annual cash incentive award for the then-current year based on the portion of the year he was employed by the Company prior to termination.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In the event that the severance pay and other benefits provided for in the Employment Agreement or otherwise payable to Dr. Bodor constitute Section 280G &#8220;parachute payments&#8221; and would be subject to excise taxes, then such benefits will be either be delivered in full or delivered as to such lesser extent which would result in no portion of such severance pay and other benefits being subject to excise taxes, whichever results in the receipt by Dr. Bodor of the greatest amount of benefits.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The foregoing description of the terms of the Employment Agreement is qualified in its entirety by reference to the Employment Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated by reference herein.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">There is no transaction between Dr. Bodor (and his immediate family) and the Company that requires disclosure in accordance with Item 404(a) of Regulation S-K.</div>

<div style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><span style="text-decoration: underline;">Victoria M. Holt Consulting Agreement</span></div>

<div style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On February 4, 2021, the Company entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;) in connection with Ms. Holt&#8217;s retirement as President and Chief Executive of the Company, effective February 28, 2021, pursuant to which Ms. Holt will provide certain consulting services to the Company. Ms. Holt has agreed to provide consulting services to the Company as an independent contractor for the period beginning on March 1, 2021 and continuing through February 28, 2022, unless terminated earlier in accordance with the terms of the Consulting Agreement. The Consulting Agreement provides that Ms. Holt will be entitled to receive compensation of $5,000 per month. Ms. Holt will also be allowed to maintain enrollment in the group health plan sponsored by the Company in accordance with the terms and conditions of the Company&#8217;s executive retiree medical plan. The Consulting Agreement may be terminated with 60 days&#8217; notice by either party for any reason.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The foregoing description of the terms of the Consulting Agreement is qualified in its entirety by reference to the Consulting Agreement, a copy of which is filed as Exhibit 10.2 hereto and incorporated by reference herein.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&#xa0;</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 9.01.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>(d) Exhibits</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.1</div>
			</td>
			<td>
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_224239.htm" style="-sec-extract:exhibit;">Executive Employment Agreement, dated January 29, 2021, by and between Proto Labs, Inc. and Robert Bodor</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.2</div>
			</td>
			<td>
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_224240.htm" style="-sec-extract:exhibit;">Consulting Agreement, dated February 4, 2021, by and between Proto Labs, Inc. and Victoria M. Holt</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">104</div>
			</td>
			<td>
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cover Page Interactive Data File (formatted as Inline XBRL)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURES</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tbody><tr>
			<td style="width: 50%;">&#xa0;</td>
			<td style="width: 50%;">PROTO LABS, INC.</td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td>Date: February 4, 2021</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td><span style="text-decoration: underline;">/s/ Victoria M. Holt&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</span></td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td>Victoria M. Holt</td>
		</tr>
		<tr>
			<td>&#xa0;</td>
			<td><i>President and </i><i>Chief </i><i>Executive</i><i> </i><i>Officer</i></td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:234pt;margin-right:0pt;margin-top:0pt;text-align:left;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_224239.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_224239.htm</title>
	<!-- Generated by ThunderDome Portal - 2/4/2021 10:19:11 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; padding:0in .1in;">
<p style="margin-bottom: 0; text-align: right; margin-top: 0; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin-bottom: 0; text-align: left; margin-top: 0; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>PROTO LABS, INC.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>EXECUTIVE EMPLOYMENT AGREEMENT</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">This <b>Executive Employment Agreement</b> (the &#8220;<i><b>Agreement</b></i>&#8221;) is entered into as of January 29, 2021 (the &#8220;<i><b>Effective Date</b></i>&#8221;) by and between <b>Proto Labs, Inc.,</b> a Minnesota corporation (the<i><b> </b></i>&#8220;<i><b>Company</b></i>&#8221;), and Robert Bodor (&#8220;<i><b>Executive</b></i>&#8221;).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: small-caps; margin: 0pt; text-align: center;"><b>Recitals</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive has been employed by the Company.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company desires to continue to employ Executive, and Executive desires to continue to be employed by the Company, in accordance with the terms and conditions stated in this Agreement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During employment with the Company Executive has had and will continue to have access to confidential, proprietary and trade secret information of the Company. It is desirable and in the best interests of the Company to protect confidential, proprietary and trade secret information of the Company, to prevent unfair competition by former executives of the Company following separation of their employment with the Company and to secure cooperation from former executives with respect to matters related to their employment with the Company.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive understands that Executive&#8217;s continued employment and receipt of the compensation and benefits provided for in this Agreement depends on, among other things, Executive&#8217;s willingness to agree to continue to abide by the non-disclosure, non-competition, non-solicitation, assignment of inventions and other covenants contained in the Proto Labs, Inc. Employee Non-Disclosure and Inventions Assignment Agreement (the &#8220;<i><b>Non-Disclosure Agreement</b></i>&#8221;) and the Proto Labs, Inc. Non-Competition Agreement (the &#8220;<i><b>Non-Competition Agreement</b></i>&#8221;) previously executed by Executive and attached together as Exhibit A to this Agreement. Executive and the Company acknowledge that Executive was provided a copy of the Non-Disclosure Agreement and the Non-Competition Agreement before Executive accepted employment with the Company, and further acknowledges that Executive was provided a copy of Executive&#8217;s signed Non-Disclosure Agreement and Executive&#8217;s signed Non-Competition Agreement before Executive executed this Agreement.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the reasons set forth above, the Company and Executive desire to enter into this Agreement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;"><font style="font-variant:small-caps;"><b>Now, Therefore,</b></font> in consideration of the foregoing and the mutual covenants set forth herein, the Company and Executive, intending to be legally bound, hereby agree as follows:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: small-caps; margin: 0pt; text-align: center;"><b>Agreements</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term.</b> Executive&#8217;s employment with the Company under the terms of this Agreement shall commence on March 1, 2021 (the &#8220;<i><b>Start Date</b></i>&#8221;) and shall continue at will until terminated by either party in accordance with the provisions of Section 6 (the &#8220;<i><b>Term</b></i>&#8221;).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employment and Duties. </b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Position and Responsibilities.</b> During the Term Executive shall serve as the Company&#8217;s President, Chief Executive Officer and shall perform such duties of an executive nature as the Company&#8217;s Board of Directors (the &#8220;<i><b>Board</b></i>&#8221;) may assign from time to time. Executive will follow and comply with applicable policies and procedures adopted by the Company from time to time, including without limitation policies relating to business ethics, conflict of interest, non-discrimination, confidentiality and protection of trade secrets, and insider trading. Executive shall devote Executive&#8217;s full working time and efforts to the Company&#8217;s business, to the exclusion of all other employment or active participation in other material business interests, unless otherwise consented to in writing by the disinterested members of the Board. Executive may not serve as a director on any other board of directors without the unanimous written consent of the Board. Executive hereby represents and confirms that Executive is under no contractual or legal commitments that Executive believes would prevent Executive from fulfilling Executive&#8217;s duties and responsibilities as set forth in this Agreement.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Board Appointment.</b>&nbsp;&nbsp;&nbsp;&nbsp;On the Start Date the Board shall appoint Executive as a director of the Company and the Board shall nominate Executive for re-election to the Board at each meeting of shareholders at which directors will be elected during the Term. Executive acknowledges and agrees that Executive is not entitled to any additional compensation in respect of Executive&#8217;s appointment as a director of the Company.&nbsp; If during the Term Executive ceases to be a director of the Company for any reason, Executive&#8217;s employment with the Company will continue (unless terminated in accordance with Section 6) and all terms of this Agreement (other than those relating to Executive&#8217;s position as a director of the Company) will continue in full force and effect and Executive will have no claims in respect of such cessation of office.<i> </i>Executive agrees to abide by all statutory, fiduciary or common law duties arising under applicable law that apply to Executive as a director of the Company.&nbsp; Executive further agrees that Executive will not resign as a director of the Company without the prior written consent of the Board and if Executive so resigns or if Executive is disqualified from acting as a director of the Company, then the Company may at its discretion terminate Executive&#8217;s employment under this Agreement for Cause (as defined in Section 6.D.).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At Will</b><b> Employment. </b>Executive&#8217;s employment with Company is at will and Executive&#8217;s employment may be unilaterally terminated by either party at any time for any reason, subject to the terms of Sections 6 and 7. The date upon which Executive&#8217;s termination of employment with the Company is effective is the &#8220;<i><b>Termination Date</b></i>.&#8221; For purposes of Section 7 only, with respect to the timing of any severance payments or benefits thereunder, the Termination Date means the date on which a &#8220;separation from service&#8221; has occurred for purposes of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &#8220;<i><b>Code</b></i>&#8221;). Unless otherwise requested by the Board in writing, upon Executive&#8217;s termination of employment with the Company for any reason Executive will automatically resign as of the Termination Date from all non-employee titles, positions and appointments Executive then holds with the Company, whether as an officer, director or trustee (without any claim for compensation related thereto), and Executive hereby agrees to take all actions necessary to effectuate such resignations.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:33.95pt;"><b>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation, Benefits and Expenses. </b>While employed by the Company during the Term, Executive will be provided with the following compensation and benefits:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63.8pt;"><b>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base Salary.</b> The Company will pay to Executive for services provided hereunder after the Start Date a base salary at the annualized rate of $500,000.00, which base salary will be paid in accordance with the Company&#8217;s normal payroll policies and procedures (&#8220;<i><b>Base Salary</b></i>&#8221;).&nbsp; Consistent with the charter of the Compensation Committee of the Board (the<i> </i>&#8220;<i><b>Compensation Committee</b></i>&#8221;) and the Company&#8217;s Corporate Governance Guidelines, the independent directors will evaluate Executive&#8217;s performance on an annual basis and then the Compensation Committee will review this evaluation and determine any adjustments to Executive&#8217;s Base Salary, subject to ratification by the Board.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63.8pt;"><b>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentive Bonus.</b> Executive will be eligible for an annual target cash incentive bonus equal to one-hundred percent (100%) of Executive&#8217;s then-current Base Salary (the &#8220;<i><b>Annual Bonus</b></i>&#8221;), based on achievement of objectives as determined by the Company, payable no later than March 15 of the calendar year following the calendar year for which the bonus was earned.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee Benefits.</b> Executive will be entitled to participate in all employee benefit plans and programs generally available to executive employees of the Company, as determined by the Company and to the extent that Executive meets the eligibility requirements for each individual plan or program. Executive&#8217;s participation in any plan or program will be subject to the provisions, rules, and regulations of, or applicable to, the plan or program. The Company provides no assurance as to the adoption or continuation of any particular employee benefit plan or program.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63.8pt;"><b>D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses.</b> The Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel, and entertainment expenses incurred by Executive in the performance of Executive&#8217;s duties and responsibilities to the Company during the Term. Such reimbursement shall be subject to the Company&#8217;s normal policies and procedures for expense verification, documentation, and reimbursement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><b>Existing and New </b><b>Equity</b><b> Awards</b><b>.</b> Executive and the Company are parties to certain existing Stock Option Agreements, Restricted Stock Unit Agreements and Performance Stock Unit Agreements (collectively, the &#8220;<i><b>Existing </b></i><i><b>Award</b></i><i><b> Agreements</b></i>&#8221;). Executive will receive an additional equity grant, 50% in the form of stock options and 50% in the form of restricted stock units, with an aggregate fair market value of $1,300,000.00 (as measured on the date of grant and based on the Board&#8217;s assessment of the Company&#8217;s performance against Executive&#8217;s and the Company&#8217;s performance objectives). The new equity grant date (the &#8220;<i><b>Grant Date</b></i>&#8221;) shall be the earliest day permitted pursuant to the terms of the Company&#8217;s Equity Award Approval Policy following commencement of the Term. These new equity awards will be subject to the terms and conditions of the applicable award agreements between the Company and Executive dated effective as of the Grant Date (the &#8220;<i><b>New </b></i><i><b>Award Agreements</b></i>&#8221;), including such terms and conditions as are incorporated from the Company&#8217;s 2012 Long-Term Incentive Plan (the &#8220;<i><b>Plan</b></i>&#8221;).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:72pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual Equity.</b> Executive shall continue to receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award; provided, however, that the annual equity grant in 2022 is expected to be 50% in the form of performance stock units, 30% in the form of restricted stock units, and 20% in the form of stock options. It is also expected that Executive&#8217;s equity grants received in 2021 will have an aggregate grant date fair value of approximately $2.0 million.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Disclosure and Non-Competition. </b>Executive acknowledges entering into the Non-Disclosure Agreement and the Non-Competition Agreement and hereby reaffirms Executive&#8217;s commitments and obligations under the Non-Disclosure Agreement and the Non-Competition Agreement. Nothing in this Agreement is intended to modify, amend, cancel or supersede the Non-Disclosure Agreement or the Non-Competition Agreement in any manner.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voluntary Termination. </b>Except as provided in Sections 6.B., C., D. and E., each party hereto may terminate Executive&#8217;s employment by giving to the other party no less than thirty (30) days prior written notice of the party&#8217;s intent to terminate. If Executive voluntarily terminates Executive&#8217;s employment without Good Reason, then the Company shall have no further liability to Executive for any payment, compensation or benefit whatsoever, other than payment of Executive&#8217;s accrued but unpaid salary and benefits through the Termination Date and honoring Executive&#8217;s rights under the Existing Award Agreements, New Award Agreements or under any other restricted stock, stock options, stock units or other equity agreement between Executive and the Company (collectively, &#8220;<i><b>Equity Awards</b></i>&#8221;). If the Company voluntarily terminates Executive&#8217;s employment without Cause (as set forth in Section 6.D.) and other than as a result of death or Disability (as set forth in Section 6.C.), or if Executive terminates Executive&#8217;s employment for Good Reason (as set forth in Section 6.E.) (either such event being a &#8220;<i><b>Qualifying Termination</b></i>&#8221;), and subject to Executive&#8217;s compliance with the conditions identified in the first paragraph of Section 7, then Executive shall be entitled to severance payments and benefits as described in and pursuant to the terms and conditions of Section 7 of this Agreement.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By Death. </b>Executive&#8217;s employment shall be terminated automatically upon the death of Executive. The Company&#8217;s total liability in such event shall be limited to payment of Executive&#8217;s accrued but unpaid salary and benefits (including Annual Bonus) through the date of Executive&#8217;s death, honoring Executive&#8217;s rights under any Equity Awards, and paying to Executive&#8217;s estate a pro rata portion of Executive&#8217;s Annual Bonus equal to one times Executive&#8217;s target annual cash incentive bonus for the calendar year in which the death occurs, less deductions and withholding required by law, payable in a lump sum at the same time as other eligible employees under the Company&#8217;s annual cash incentive bonus plan for such calendar year are paid their bonuses under such Company&#8217;s annual cash incentive bonus plan<b> </b>for such calendar year, but in any event no later than March 15 of the calendar year immediately following the calendar year in which Executive&#8217;s death occurs. Such pro rata bonus payment shall be determined by multiplying Executive&#8217;s target annual cash incentive bonus for the calendar year in which the death occurs by a fraction, the numerator of which is the number of days Executive was employed by the Company during such calendar year and the denominator is 365.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By Disability. </b>The Company may terminate Executive&#8217;s employment upon the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive&#8217;s employment with the Company, after any reasonable accommodation that may be required under applicable law is made by the Company, by reason of Executive&#8217;s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of one hundred and twenty (120) days (a &#8220;<i><b>Disability</b></i>&#8221;). A period of inability shall be &#8220;uninterrupted&#8221; unless and until Executive returns to full-time work for a continuous period of at least thirty (30) days. The Company shall have no liability for severance pay or benefits following the Termination Date due to Disability, other than payment of Executive&#8217;s accrued but unpaid salary and benefits (including Annual Bonus) through the date of Executive&#8217;s Disability, honoring Executive&#8217;s rights under any Equity Awards, honoring any rights Executive has to disability insurance benefits under applicable law or the Company&#8217;s short or long term disability insurance policies as in effect as of the Termination Date, and paying to Executive a pro rata portion of Executive&#8217;s Annual Bonus equal to one times Executive&#8217;s target annual cash incentive bonus for the calendar year in which the Termination Date due to Disability occurs, less deductions and withholding required by law, payable in a lump sum at the same time as other eligible employees under the Company&#8217;s annual cash incentive bonus plan for such calendar year are paid their bonuses under such Company&#8217;s annual cash incentive bonus plan<b> </b>for such calendar year, but in any event no later than March 15 of the calendar year immediately following the calendar year in which the Termination Date due to Disability occurs. Such pro rata bonus payment shall be determined by multiplying Executive&#8217;s target annual cash incentive bonus for the calendar year in which the Termination Date due to Disability occurs by a fraction, the numerator of which is the number of days Executive was employed by the Company during such calendar year and the denominator is 365.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For Cause. </b>The employment relationship between Executive and the Company created hereunder shall automatically and immediately terminate upon receipt by Executive of notice of termination for Cause after the occurrence of any one of the following events:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(i)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive&#8217;s intentional and knowing failure or refusal to perform satisfactorily the material duties reasonably required of Executive by the Board (other than by reason of Disability);</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(ii)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive&#8217;s material and knowing violation of any law, rule, regulation, court order or regulatory directive (other than traffic violations, misdemeanors or other minor offenses);</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iii)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive&#8217;s material breach of the Non-Disclosure Agreement, the Non-Competition Agreement, or any Company code of conduct and Executive&#8217;s failure to cure such material breach (if curable) within ten (10) days of receipt of notice of such material breach;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iv)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive engaging in any act or practice that involves personal dishonesty on the part of Executive or demonstrates a willful and continuing disregard for the best interests of the Company or its affiliates; or</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(v)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While performing corporate duties and responsibilities, Executive engaging in conduct that would be reasonably expected to harm or bring disrepute to the Company or any of its affiliates.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Good Reason. </b>Executive&#8217;s voluntary resignation of Executive&#8217;s employment under this Agreement will be considered to be with &#8220;<i><b>Good Reason</b></i>&#8221; if, following the occurrence of one or more of the events listed below, Executive (1) provides written notice to the Board of the event(s) constituting Good Reason within sixty (60) days after the first occurrence of such event(s), (2) the Company fails to reasonably cure such event(s) within thirty (30) days after receiving such notice, and (3) the Termination Date is not later than thirty (30) days after the end of the period in which the Board may cure the event(s). For the avoidance of doubt, Executive will not be entitled to any compensation or benefits pursuant to this Agreement if Executive voluntarily resigns from Executive&#8217;s employment without Good Reason. The following events will give rise to Good Reason, unless Executive has consented thereto in writing:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(i)&nbsp;</b>&nbsp;&nbsp;&nbsp;&nbsp;a material reduction in Executive&#8217;s total compensation, which is comprised of base salary, target incentive bonus and annual equity grants, other than a reduction that is part of and proportionally consistent with a broad-based reduction in base compensation, target incentive bonus or annual equity grants applicable to the Company&#8217;s senior executives (provided, however, that any reduction in Executive&#8217;s Base Salary below $400,000.00 for any year during the Term without Executive&#8217;s consent will constitute a material reduction for purposes of this Good Reason definition);</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(ii)&nbsp;</b>&nbsp;&nbsp;&nbsp;&nbsp;a material diminution in Executive&#8217;s authority, duties or responsibilities;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iii)&nbsp;</b>&nbsp;&nbsp;&nbsp;&nbsp;a change in the location of the Company facility or office where Executive is based to a location more than fifty (50) miles from the Company facility or office where Executive is based as of the Start Date; or</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iv)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a material breach by the Company of any terms or conditions of this Agreement or any other agreement between Executive and the Company, which breach has not been cured by the Company within fifteen (15) days after written notice thereof to the Company from Executive.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance. </b>If there is a Qualifying Termination, provided that Executive&#8217;s termination of employment constitutes an involuntary &#8220;separation from service&#8221; under Section 409A of the Code (&#8220;<i><b>Section 409A</b></i>&#8221;), and provided that Executive signs and does not rescind a general waiver and release of claims in favor of the Company and its affiliates in a form to be prescribed by the Company (the &#8220;<i><b>Release</b></i>&#8221;) (with such Release carving out typical post-termination matters from such Release, including but not limited to any severance obligations and vested rights of Executive and/or obligations of the Company to indemnify Executive for claims arising out of or related to service as an officer or director of the Company), and provided further that Executive is in compliance with Executive&#8217;s continuing obligations to the Company (including but not limited to those in the Non-Disclosure Agreement and the Non-Competition Agreement), then Executive will receive the severance payments and benefits identified in this Section 7. If Executive becomes eligible to receive any severance payments or benefits under this Section 7 then Executive will not be eligible to receive any severance payments or benefits under any other agreement between Executive and the Company or under any severance plan or program adopted by the Company. Notwithstanding any provisions in this Agreement to the contrary, if any severance plan or program adopted by the Company (&#8220;<i><b>Other Severance Plan</b></i>&#8221;) permits Executive to receive greater severance benefits than contemplated under this Agreement, then Executive may, in Executive&#8217;s sole discretion, elect to receive the severance benefits permitted under the Other Severance Plan in lieu of all severance benefits payable to Executive under this Agreement; provided, however, any such election by Executive shall be made at least twelve (12) months prior to the Termination Date and may not otherwise violate any applicable restrictions under Section 409A.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments Upon </b><b>Qualifying </b><b>Termination Prior to a Change in Control or After the Expiration of the Transition Period.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(i)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Qualifying Termination (Other than During the Transition Period).</b> If the Termination Date occurs during the Term and is prior to any Change in Control (as defined below) or after the Transition Period (as defined below), and if such termination is a Qualifying Termination, then, in addition to such base salary, bonus and benefits that have been earned but not paid to Executive as of the Termination Date, and subject to Executive satisfying the conditions identified in the first paragraph of this Section 7, the Company shall provide to Executive the following severance payments and benefits:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 117pt;"><b>(a)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Base Salary Cash Severance.</b> The Company shall pay to Executive an amount equal to one times Executive&#8217;s annualized Base Salary as of the Termination Date (or, if Executive&#8217;s resignation is for Good Reason because the Company materially reduced Executive&#8217;s Base Salary, one times Executive&#8217;s annualized Base Salary as of immediately before such material reduction), less deductions and withholding required by law, payable in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 12-month period immediately following the Termination Date; provided, however that any installments that otherwise would be payable within the 60-day period immediately following the Termination Date shall be delayed and payable with the installment that is payable on the Company&#8217;s first payroll date following the 60th day after the Termination Date. Notwithstanding anything above to the contrary, in no event will the amount paid under the first sentence of this Section 7.A.(i)(a) exceed the lesser of two times (I) the limit of compensation set forth in section 401(a)(17) of the Code as in effect for the year in which the Termination Date occurs, or (II) Executive&#8217;s annualized compensation based upon the annual rate of pay for services to the Company for the calendar year prior to the calendar year in which the Termination Date occurs (adjusted for any increase during that year that was expected to continue indefinitely if Executive had not separated from service). If Executive&#8217;s severance pay as calculated under the first sentence of this Section 7.A.(i)(a) is limited by application of clause (I) or (II) of the second sentence of this Section 7.A.(i)(a), then the Company shall make an additional separate lump sum payment to Executive equal to the difference between (x) the amount payable to Executive under the first sentence of this Section 7.A.(i)(a) but for the application of clause (I) or (II) of the second sentence of this Section 7.A.(i)(a), and (y) the amount payable to Executive under the second sentence of this Section 7.A.(i)(a) as a result of the application of clause (I) or (II) of the second sentence of this Section 7.A.(i)(a). Such lump sum payment shall be a separate payment from the installment payments provided under this Section 7.A.(i)(a) and shall be paid to Executive on the Company&#8217;s first payroll date following the 60th day after the Termination Date but in no event later than 75 days after the Termination Date.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash Bonus Payment.</b> The Company shall pay to Executive an amount equal to one times Executive&#8217;s target annual cash incentive bonus for the calendar year in which the Termination Date occurs, less deductions and withholding required by law, payable in a lump sum at the same time as other eligible employees under the Company&#8217;s annual cash incentive bonus plan for such calendar year are paid their bonuses under such Company&#8217;s annual cash incentive bonus plan<b> </b>for such calendar year, but in any event no later than March 15 of the calendar year immediately following the calendar year in which the Termination Date occurs.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefits Continuation.</b> If Executive was enrolled in a group health plan (<i>e.g.</i>, medical, dental, or vision plan) sponsored by the Company immediately prior to the Termination Date, and if Executive (or Executive&#8217;s eligible dependents) timely elects to continue such coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (together with any state law of similar effect, &#8220;<i><b>COBRA</b></i>&#8221;), then the Company will pay to the insurance carrier(s) its share of the premiums due for Executive and Executive&#8217;s eligible dependents for the first twelve (12) months of such coverage under COBRA (or until such earlier time as Executive and/or Executive&#8217;s eligible dependents are no longer eligible for COBRA coverage).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro Rata Accelerated Vesting of Equity. </b>Notwithstanding any language in any Equity Award or in the Plan to the contrary, if Executive has an unvested option to purchase Shares (as defined in the Plan) or any unvested Stock Units (as defined in the Plan) under any Equity Award under the Plan addressing Executive&#8217;s option to purchase or right or have vest Shares, then a pro rata portion of any such time-based award scheduled to vest on the next anniversary of the grant date for such award will vest as of the Termination Date and a pro rata portion of any such performance-based award will vest as provided below. In the case of time-based awards, the number of additional Shares that Executive will have the option to purchase or will have vest as a result of such pro rata vesting will be determined by multiplying the total number of additional Shares Executive would have had the option to purchase, or have had vest, as of the next anniversary of the grant date for such award assuming Executive would have remained employed through such anniversary by a fraction, the numerator of which is the number of days Executive was employed by the Company during the then-current vesting year through and including the Termination Date and the denominator is 365. For performance-based awards, the number of additional Shares that Executive will have vest as a result of such pro rata vesting will be determined by multiplying the total number of additional Shares that would otherwise have been determined to have been earned had Executive remained employed through the end of the applicable performance period by a fraction, the numerator of which is the number of days Executive was employed by the Company during the performance period and the denominator is the number of days in the performance period (<i>e.g.</i>, 1,095 days in the case of a three-year performance period).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Termination (Other Than During the Transition Period).</b> If the Termination Date occurs for any reason after expiration of the Term (subject to Section 7.C.), or if the Termination Date occurs during the Term and is prior to any Change in Control or after the Transition Period for any of the following reasons: (a) Executive&#8217;s abandonment of or resignation from employment for any reason other than Good Reason; (b) termination of Executive&#8217;s employment by the Company for Cause; or (c) due to Executive&#8217;s death or Disability, then the Company shall pay to Executive, or Executive&#8217;s beneficiary or estate, as the case may be, such base salary, bonus and benefits (including Annual Bonus) that have been earned but not paid to Executive as of the Termination Date, payable pursuant to the Company&#8217;s normal payroll practices and procedures and to the extent and in the manner provided in any applicable plans or programs, pay any additional amount that may be payable under Section 6.B. Section 6.C. (as applicable) and honor Executive&#8217;s rights under any Equity Awards, and Executive shall not be entitled to any additional compensation or benefits.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments Upon Termination During the Transition Period.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Qualifying Termination During the Transition Period.</b> If a Change in Control occurs during the Term and Executive&#8217;s Termination Date occurs on the date of the Change in Control or prior to the 18-month anniversary of the Change in Control (such 18-month period, the &#8220;<i><b>T</b></i><i><b>ransition Period</b></i>&#8221;), and if such termination is a Qualifying Termination, then, in addition to such base salary, bonus and benefits that have been earned but not paid to Executive as of the Termination Date, and subject to Executive satisfying the conditions identified in the first paragraph of this Section 7, the Company shall provide to Executive the following severance payments and benefits:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(a)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Base Salary Cash Severance.</b> The Company shall pay to Executive an amount equal to two times Executive&#8217;s annualized Base Salary as of the Termination Date (or, if Executive&#8217;s resignation is for Good Reason because the Company materially reduced Executive&#8217;s Base Salary, two times Executive&#8217;s annualized Base Salary as of immediately before such material reduction), less deductions and withholding required by law, payable in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 24-month period immediately following the Termination Date; provided, however that any installments that otherwise would be payable within the 60-day period immediately following the Termination Date shall be delayed and payable with the installment that is payable on the Company&#8217;s first payroll date following the 60th day after the Termination Date. Notwithstanding anything above to the contrary, in no event will the amount paid under the first sentence of this Section 7.B.(i)(a) exceed the lesser of two times (I) the limit of compensation set forth in section 401(a)(17) of the Code as in effect for the year in which the Termination Date occurs, or (II) Executive&#8217;s annualized compensation based upon the annual rate of pay for services to the Company for the calendar year prior to the calendar year in which the Termination Date occurs (adjusted for any increase during that year that was expected to continue indefinitely if Executive had not separated from service). If Executive&#8217;s severance pay as calculated under the first sentence of this Section 7.B.(i)(a) is limited by application of clause (I) or (II) of the second sentence of this Section 7.B.(i)(a), then the Company shall make an additional lump sum payment to Executive equal to the difference between (x) the amount payable to Executive under the first sentence of this Section 7.B.(i)(a) but for the application of clause (I) or (II) of the second sentence of this Section 7.B.(i)(a), and (y) the amount payable to Executive under the second sentence of this Section 7.B.(i)(a) as a result of the application of clause (I) or (II) of the second sentence of this Section 7.B.(i)(a). Such lump sum payment shall be a separate payment from the installment payments provided under this Section 7.B.(i)(a) and shall be paid to Executive on the Company&#8217;s first payroll date following the 60th day after the Termination Date but in no event later than 75 days after the Termination Date.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash Bonus Payment.</b> The Company shall pay to Executive an amount equal to two times Executive&#8217;s target annual cash incentive bonus for the calendar year in which the Termination Date occurs, less deductions and withholding required by law, payable in a lump sum at the same time as other eligible employees under the Company&#8217;s annual cash incentive bonus plan for such calendar year are paid their bonuses under such Company&#8217;s annual cash incentive bonus plan<b> </b>for such calendar year, but in any event no later than March 15 of the calendar year immediately following the calendar year in which the Termination Date occurs.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefits Continuation.</b> If Executive was enrolled in a group health plan (<i>e.g.</i>, medical, dental, or vision plan) sponsored by the Company immediately prior to the Termination Date, and if Executive (or Executive&#8217;s eligible dependents) timely elects to continue such coverage under COBRA, then the Company will pay to the insurance carrier(s) its share of the premiums due for Executive and Executive&#8217;s eligible dependents for the first eighteen (18) months of such coverage under COBRA (or until such earlier time as Executive and/or Executive&#8217;s eligible dependents are no longer eligible for COBRA coverage).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 126pt;"><b>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Full Accelerated Vesting of Equity. </b>Notwithstanding any language in any Equity Award or in the Plan to the contrary, if Executive has any unvested awards of restricted stock units, options or other equity-based awards with respect to the Company as of the Termination Date, then any such unvested awards will vest immediately as of the Termination Date. In the case of performance-based awards, the number of Shares subject to such accelerated vesting shall be based on a determination by the Board of the degree to which any performance-based vesting conditions will be deemed satisfied.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Termination During the Transition Period.</b> If the Termination Date occurs during the Transition Period for any of the following reasons: (a) Executive&#8217;s abandonment of or resignation from employment for any reason other than Good Reason; (b) termination of Executive&#8217;s employment by the Company for Cause; or (c) due to Executive&#8217;s death or Disability, then the Company shall pay to Executive, or Executive&#8217;s beneficiary or estate, as the case may be, such base salary, bonus and benefits (including Annual Bonus) that have been earned but not paid to Executive as of the Termination Date, payable pursuant to the Company&#8217;s normal payroll practices and procedures and to the extent and in the manner provided in any applicable plans or programs, pay any additional amount that may be payable under Section 6.B. or Section 6.C. (as applicable) and honor Executive&#8217;s rights under any Equity Awards, and Executive shall not be entitled to any additional compensation or benefits.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><b>Additional Payments Upon or Following a Change in Control. </b>If the Termination Date occurs during the Term and within ninety (90) days prior to a Change in Control, and if such termination is a Qualifying Termination and Executive reasonably demonstrates within thirty (30) days after the Change in Control that such Qualifying Termination arose in connection with or in anticipation of the Change in Control, then the Company shall provide to Executive the following severance payments and benefits (in addition to the severance payments and benefits Executive is eligible to receive under Section 7.A.), each of which shall be considered a separate payment:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay to Executive an amount equal to one times Executive&#8217;s annualized Base Salary as of the Termination Date (or, if Executive&#8217;s resignation was for Good Reason because the Company materially reduced Executive&#8217;s Base Salary, one times Executive&#8217;s annualized Base Salary as of immediately before such material reduction), less deductions and withholding required by law, payable in a lump sum on the Company&#8217;s first payroll date following the 60th day after the Termination Date but in no event later than 75 days after the Termination Date. Such lump sum payment shall be a separate payment from any payments under Section 7.A.(i)(a).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(ii)</b> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay to Executive an amount equal to one times Executive&#8217;s target annual cash incentive bonus for the calendar year in which the Termination Date occurred, less deductions and withholding required by law, payable as follows: (a) if the Change in Control and the Termination Date occur in the same calendar year, then in a lump sum at the same time as other eligible employees under the Company&#8217;s annual cash incentive bonus plan for such calendar year are paid their bonuses under such Company&#8217;s annual cash incentive bonus plan<b> </b>for such calendar year, but in any event no later than March 15 of the calendar year immediately following the calendar year in which the Termination Date occurred, or (b) if the Change in Control occurs in the calendar year following the year in which the Termination Date occurred, then in a lump sum not later than 60 days after the Change in Control.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iii)</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If Executive was enrolled in a group health plan (<i>e.g.</i>, medical, dental, or vision plan) sponsored by the Company immediately prior to the Termination Date, and if Executive (or Executive&#8217;s eligible dependents) timely elects to continue such coverage under COBRA, then the Company will pay to the insurance carrier(s) its share of the premiums due for Executive and Executive&#8217;s eligible dependents for six (6) months of such coverage under COBRA after the initial 12-month COBRA coverage period under Section 7.A.(i)(c) ends (or until such earlier time as Executive and/or Executive&#8217;s eligible dependents are no longer eligible for COBRA coverage).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;"><b>(iv)</b> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay to Executive an amount equal to the intrinsic value of any unvested restricted stock units, options or other equity-based awards held by Executive as of the Termination Date that were forfeited as of the Termination Date, with such intrinsic value to be determined based on the per share price paid by the buyer for the Company&#8217;s common stock in connection with the Change in Control, or, if no per share price is paid by a buyer in connection with such Change in Control, the per share value of the Company&#8217;s common stock at the time of such Change in Control as determined in good faith by the Board as it exists prior to the consummation of the Change in Control, in each case, less any exercise price or other amount that would have been owed to the Company by Executive in order to realize the value of such awards. In the case of forfeited performance-based awards, the intrinsic value shall be based on the number of Shares subject to an award based on a determination by the Board of the degree to which any performance-based vesting or payment conditions will be deemed satisfied. Any amount payable under this Section 7.C.(iv) will be subject to deductions and withholding required by law and payable in a lump sum within the 30-day period immediately following the Change in Control.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:108pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>D.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Change in Control.</b> For purposes of this Agreement, &#8220;<i><b>Change in Control</b></i>&#8221; has the meaning ascribed to such term in the Plan (as such document may be amended from time to time).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>E.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Section 409A; Conditional Six-Month Delay.</b> Any payments under this Section 7 (the &#8220;<i><b>Payments</b></i>&#8221;) are intended to be exempt from or satisfy the requirements for deferred compensation under Section 409A, including current and future guidance and regulations interpreting Section 409A, and should be interpreted and administered accordingly. However, if the Company (or, if applicable, the successor entity thereto) determines that the Payments (or any portion of the Payments) constitute &#8220;deferred compensation&#8221; under Section 409A and Executive is a &#8220;specified employee&#8221; of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) (a &#8220;<i><b>Specified Employee</b></i>&#8221;), then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the Payments shall be delayed as follows: on the earliest to occur of (i) the date that is six months and one day after the Termination Date, (ii) the date of the Specified Employee&#8217;s death, or (iii) such earlier date, as reasonably determined in good faith by the Company (or any successor entity thereto), as would not result in any of the Payments being subject to adverse personal tax consequences under Section 409A (such earliest date, the &#8220;<i><b>Delayed Initial Payment Date</b></i>&#8221;), the Company (or the successor entity thereto, as applicable) shall (A) pay to Executive a lump sum amount equal to the sum of the Payments that Executive would otherwise have received through the Delayed Initial Payment Date if the commencement of the payment of the Payments had not been delayed pursuant to this Section 7.E. and (B) commence paying the balance of the Payments in accordance with the applicable payment schedules set forth in Section 7 above. For the avoidance of doubt, it is intended that (1) each installment of the Payments is a separate &#8220;payment&#8221; for purposes of Section 409A, (2) all Payments satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under of Treasury Regulation 1.409A-1(b)(4)-(6), and 1.409A-1(b)(9)(iii), and (3) the Payments consisting of COBRA premiums also satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulation 1.409A-1(b)(9)(v).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><b>280G Limitations.</b> In the event that the severance pay and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) would be subject to the excise tax imposed by Code Section 4999, then such benefits shall be either be: (A) delivered in full, or (B) delivered as to such lesser extent which would result in no portion of such severance pay and other benefits being subject to excise tax under Code Section 4999, whichever of the foregoing amounts, taking into account the applicable federal, state and local income and employment taxes and the excise tax imposed by Code Section 4999, results in the receipt by Executive, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be subject to excise tax under Code Section 4999. Any determination required under this Section 7.F. will be made in writing by an accounting firm selected by the Company or such other person or entity to which the parties mutually agree (the &#8220;<i><b>Accountants</b></i>&#8221;), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 7.F., the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Code Sections 280G and 4999. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 7.F. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 7.F. Any reduction in payments and/or benefits required by this Section 7.F. shall occur in the following order: (i) cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced; (ii) accelerated vesting of restricted stock units, options or other equity-based awards, if any, shall be cancelled/reduced next and in the reverse order of the date of grant for such restricted stock units, options or other equity-based awards (i.e., the vesting of the most recently granted stock awards will be reduced first), with full-value awards reversed before any restricted stock units, options or other equity-based awards are reduced; and (iii) deferred compensation amounts subject to Section 409A shall be reduced last.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remedies. </b>Each of the parties to this Agreement will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights existing in its favor. The parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that any party may in its sole discretion apply to any court of law or equity of competent jurisdiction in accordance with Section 12 for injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attorney Fees. </b>If any action at law or in equity, including any action for declaratory or injunctive relief, is brought which arises out of this Agreement or the termination of Executive&#8217;s employment, or which seeks to enforce or interpret this Agreement or to seek damages for its breach, the prevailing party shall be entitled to recover reasonable attorney fees from the non-prevailing party, which fees may be set by the court or arbitrator in the trial of such action, or may be enforced in a separate action brought for that purpose, and which fees shall be in addition to any other relief which may be awarded.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assignment. </b>This Agreement shall not be assignable, in whole or in part, by either party without the written consent of the other party, except that the Company may, without the consent of Executive, assign or delegate all or any portion of its rights and obligations under this Agreement to any corporation or other business entity (i) with which the Company may merge or consolidate, or (ii) to which the Company may sell or transfer all or substantially all of its assets or capital stock. Notwithstanding the Company&#8217;s right to assign this Agreement contemplated herein, Executive&#8217;s restrictive covenants set forth in the Non-Competition Agreement shall not expand in scope as a result of such assignment in connection with a Change in Control without Executive&#8217;s prior written consent if Executive is not employed by the Company as of the date of and immediately following such assignment in connection with a Change in Control (for example, Executive shall not be prohibited from competing against products or services of the acquiring or surviving entity in the event of a Change in Control if the Company did not sell such services or product lines prior to such Change in Control if Executive is not employed by the Company as of the date of and immediately following the Change in Control).&nbsp; Any such current or future successor to which any right or obligation has been assigned or delegated shall be deemed to be the &#8220;Company&#8221; for purposes of such rights or obligations of this Agreement. The rights and, obligations under this Agreement shall inure to the benefit of and shall be binding upon the heirs, legatees, administrators and personal representatives of Executive and upon the successors, affiliates, representatives and assigns of the Company.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severability and Reformation. </b>The parties hereto intend all provisions of this Agreement to be enforced to the fullest extent permitted by law, and are intended to be limited to the extent necessary so that they will not render this Agreement illegal, invalid, or unenforceable under present or future law. If any provision of this Agreement or any application thereof shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of such provision shall be fully severable, and this Agreement shall be construed and enforced as if such illegal, invalid, or unenforceable provision were never a part hereof and the remaining provisions shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notices. </b>All notices and other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have been duly given if delivered personally, mailed by certified mail (return receipt requested) or sent by overnight delivery service, cable, telegram, facsimile transmission or telex to the parties at the following addresses or at such other addresses as shall be specified by the parties by like notice:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">If to the Company:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Proto Labs, Inc.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">5540 Pioneer Creek Drive</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Maple Plain, MN 55359</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Attention: Board Chair</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">If to Executive:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Robert Bodor</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The last known address on file with the Company.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Notice so given shall, in the case of notice so given by mail, be deemed to be given and received on the fourth calendar day after posting, in the case of notice so given by overnight delivery service, on the date of actual delivery and, in the case of notice so given by cable, telegram, facsimile transmission, telex or personal delivery, on the date of actual transmission or, as the case may be, personal delivery.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further Actions. </b>Whether or not specifically required under the terms of this Agreement, each party hereto shall execute and deliver such documents and take such further actions as shall be necessary in order for such party to perform all of the party&#8217;s obligations specified herein or reasonably implied from the terms hereof.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>The Company may withhold from any amounts payable under this Agreement such federal, state and local income and employment taxes as the Company determines are required or authorized to be withheld pursuant to any applicable law or regulation. Except for any tax amounts withheld by the Company from any compensation that Executive may receive in connection with Executive&#8217;s employment with the Company and any employer taxes required to be paid by the Company under applicable laws or regulations, Executive is solely responsible for payment of any and all taxes owed in connection with any compensation, benefits, reimbursement amounts or other payments Executive receives from the Company under this Agreement or otherwise in connection with Executive&#8217;s employment with the Company. The Company does not guarantee any particular tax consequence or result with respect to any payment made by the Company. In no event should this Section 14 or any other provision of this Agreement be construed to require the Company to provide any gross-up for the tax consequences of any provisions of, or payments under, this Agreement, and the Company has no responsibility for tax or legal consequences to Executive resulting from the terms or operation of this Agreement; provided, however, to the extent that any post-termination COBRA premiums paid by the Company under Section 7 of this Agreement shall be taxable at the Termination Date or during the period for which such COBRA premiums are provided, then the Company shall pay to Executive an additional amount for each such month that the COBRA premiums are taxable.&nbsp; The monthly amount will equal 15% of the applicable COBRA premium for that month and such amount will be paid to Executive within two and one half months after the month to which they relate, provided that the aggregate amount payable to Executive under this provision will not exceed the dollar limit in effect under Code section 402(g)(1)(B) for the year of the Termination Date, as provided in Treasury Regulations section 1.409A-1(b)(9)(v)(D).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>15.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Indemnification</b>. At all times while Executive is employed by the Company, and at all times following the Termination Date with respect to matters relating to Executive&#8217;s employment with the Company, the Company shall continue to provide to Executive indemnification, director&#8217;s and officer&#8217;s liability insurance and other protection from personal liability with respect to Executive&#8217;s employment with the Company in accordance with applicable law, the Company&#8217;s by-laws and governance documents, and applicable insurance policies as may be in place from time to time.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governing Law and Venue. </b>This Agreement is to be governed by and construed in accordance with the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule that would cause the application of laws of any jurisdiction other than the State of Minnesota. The parties agree that any dispute concerning this Agreement is to be brought in the District Court in Hennepin County, Minnesota and consent to jurisdiction and venue therein.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement. </b>This Agreement, the Non-Disclosure Agreement, the Non-Competition Agreement, the Existing Award Agreements, the New Award Agreements and the Plan contain the entire understanding and agreement between the parties, except as otherwise specified herein, and supersede any other agreement between Executive and the Company, whether oral or in writing, with respect to the same subject matter; <i>provided, however</i>, that nothing herein shall supersede or replace any of the Company&#8217;s equity-based compensation plans and any award agreements with the Executive entered into thereunder.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>18</b><b>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Waiver. </b>No term or condition of this Agreement shall be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Counterparts. </b>This Agreement may be executed in counterparts, with the same effect as if both parties had signed the same document. All such counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><i>[signature page follows]</i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;"><font style="font-variant:small-caps;"><b>In Witness Whereof</b></font>, the parties have executed this Agreement as of the Effective Date first above written.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:68.5%;margin-top:0pt;text-align:left;"><b>THE COMPANY: </b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>Proto Labs, Inc.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By<u> /s/ John Way &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; </u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;"><u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>EXECUTIVE:</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><u>/s/ Robert Bodor &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; </u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Robert Bodor</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex_224240.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_224240.htm</title>
	<!-- Generated by ThunderDome Portal - 2/4/2021 10:19:38 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0; text-align: right; margin-top: 0; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.2</b></font></p>

<p style="margin-bottom: 0; text-align: left; margin-top: 0; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><u><b>CONSULTING AGREEMENT</b></u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This Consulting Agreement (this &#8220;<u>Agreement</u>&#8221;) is made and entered into by and between Proto Labs, Inc., a Minnesota corporation (the &#8220;<u>Company</u>&#8221;), and Victoria M. Holt, a resident of the State of Minnesota (the &#8220;<u>Consultant</u>&#8221;), effective as of February 4, 2021 (the &#8220;<u>Effective Date</u>&#8221;).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>RECITALS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>WHEREAS,</b> the Consultant is employed by the Company as its Chief Executive Officer.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>WHEREAS,</b> the Consultant&#8217;s employment with the Company is anticipated to continue through February 28, 2021, the Consultant&#8217;s employment retirement date, with such employment continuing to be in accordance with the terms of the Amended and Restated Executive Employment Agreement by and between the Company and Consultant entered into as of August 1, 2019 (including Exhibit A thereto, the &#8220;Employment Agreement&#8221;).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>WHEREAS,</b> the Company and the Consultant have agreed that following Consultant&#8217;s retirement from employment with the Company, beginning on March 1, 2021, the Company will engage the Consultant to provide consulting services to the Company pursuant to the terms of this Agreement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>WHEREAS,</b> during the Consulting Period (as defined below), the Consultant will have access to confidential, proprietary and trade secret information of the Company, and it is desirable and in the best interests of the Company and its shareholders to protect confidential, proprietary and trade secret information of the Company, and to secure cooperation from Consultant with respect to matters related to her engagements with the Company.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>WHEREAS,</b> the Consultant understands that the Consultant&#8217;s receipt of the compensation provided for in this Agreement depends on, among other things, the Consultant&#8217;s willingness to agree to and abide by the Confidentiality Agreement (as defined below) and other covenants referenced in this Agreement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>NOW THEREFORE,</b> in consideration of the mutual promises and provisions contained in this Agreement referred to below, the parties hereto, intending to be legally bound, agree as follows:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><u><b>Consulting Services</b></u><b>. </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consulting Services. </b>The Consultant will provide reasonable consulting services to the Company in connection with the Company Business, as an independent contractor for the period beginning on March 1, 2021 and continuing through February 28, 2022, unless terminated earlier in accordance with Section 2 (the &#8220;<u>Consulting Period</u>&#8221;). The Consultant agrees to render consulting services of the nature described in Schedule 1 attached hereto as may be requested from time to time by the Company during the Consulting Period (the &#8220;<u>Consulting Services</u>&#8221;). The Consultant may determine, in the Consultant&#8217;s sole discretion, the means and manner of performing the Consulting Services. The Company retains the right to require that the Consultant satisfactorily perform the Consulting Services. Subject to the Consultant&#8217;s specific obligations under this Agreement and the Confidentiality Agreement, nothing in this Agreement or the Confidentiality Agreement shall prohibit the Consultant from providing services to other persons or entities during the Consulting Period, provided that doing so does not (i) prevent the Consultant from performing the terms of this Agreement or (ii) violate the terms of the Confidentiality Agreement or the Employment Agreement.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:72pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consulting Fee. </b>For the Consultant&#8217;s Consulting Services during the Consulting Period, the Consultant will receive a consulting fee of $5,000.00 per month (the &#8220;<u>Consulting Fee</u>&#8221;), with the Consulting Fee payable on or about the last business day of each month during the Consulting Period (beginning on or about March 31, 2021). All installments of the Consulting Fee shall cease upon the termination of the Consulting Period, in accordance with this Agreement, with any final Consulting Fee prorated for the final partial month on the Consulting Period if the Consulting Period is terminated by either party in accordance with Section 2 before February 28, 2022.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefits Continuation.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As additional consideration for the Consultant entering into this Agreement, if the Consultant was enrolled in a group health plan (e.g., medical, dental, or vision plan) sponsored by the Company prior to the separation of her employment with the Company, and if the Consultant timely elects to continue such coverage, then the Consultant will be allowed to continue to be covered under such group health plan in accordance with the terms and conditions of the Company&#8217;s applicable executive retiree medical plan.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:72pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses During the Consulting Period. </b>The Company will reimburse the Consultant for any reasonable expenses incurred by the Consultant during the Consulting Period, including travel, provided however, that all reimbursements of the Consultant&#8217;s out-of-pocket expenses exceeding $1,000.00 are approved by the Company in writing and in advance of being incurred and that expenses of any amount are submitted in a form acceptable to the Company with documentation substantiating the expense and are consistent with the Company&#8217;s then-current expense reimbursement policies.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:72pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;"><b>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent Contractor Relationship. </b>The Consultant&#8217;s relationship to the Company during the Consulting Period shall be that of an independent contractor. For the Consultant&#8217;s performance of the Consulting Services, the Consultant shall not be treated as an employee of the Company and shall not be entitled to any compensation or benefits provided to employees of the Company. The Company will not withhold FICA or income tax payments from any amounts payable to the Consultant under this Agreement, and the Consultant shall be solely responsible for the payment of any income, employment, or other taxes owing with respect to compensation paid to or on behalf of the Consultant under this Agreement. The Company does not guarantee any particular tax consequence or result with respect to any compensation paid to or on behalf of the Consultant under this Agreement. The Consultant shall indemnify and hold the Company harmless against any claim or liability (including penalties) resulting from failure of the Consultant to pay such taxes or contributions, or failure of the Consultant to file any such tax forms.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>&nbsp;<u><b>Termination</b></u><b>. </b>Notwithstanding any other language in this Agreement, the Company may terminate the Consulting Period and this Agreement under the following circumstances: (i) immediately upon the Consultant&#8217;s material failure or refusal to perform satisfactorily the Consulting Services, (ii) immediately upon a material breach of this Agreement, the Confidentiality Agreement or the Employment Agreement by the Consultant, (iii) immediately if the Consultant engages in any act that involves material dishonesty or demonstrates a willful and continuing disregard for the best interests of the Company, or (iv) for any other reason upon no less than sixty (60) days&#8217; notice to the Consultant. Notwithstanding any other language in this Agreement, the Consultant may terminate the Consulting Period and this Agreement under the following circumstances: (i) immediately upon a material breach of this Agreement by the Company, or (ii) for any other reason upon no less than sixty (60) days&#8217; notice to the Consultant.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><u><b>Return of Property</b></u><b>. </b>Upon termination of the Consultant&#8217;s services to the Company, or at any earlier time upon request from the Company, the Consultant shall deliver promptly to the Company all property of the Company that is in the Consultant&#8217;s possession or under the Consultant&#8217;s control, including any computers, cellular telephones, credit cards, keys, records, files, documents, data, computer disks and other computer storage media.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>4.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><b>Cooperation</b></u><b>. </b>The Consultant agrees to cooperate with the Company with respect to any business matters about which the Consultant has knowledge relating to matters encompassed within the Consulting Services, including any litigation or threatened litigation. It is agreed and understood that (a) the Company&#8217;s request(s) to cooperate after the end of the Consulting Period will be scheduled for such times and places as do not interfere with the Consultant&#8217;s prior business or personal commitments, and (b) in providing such cooperation after the end of the Consulting Period, the Consultant shall be paid a reasonable consulting fee, and any out-of-pocket expenses incurred by the Consultant shall be promptly reimbursed upon presentation of reasonable expense documentation in accordance with the terms set forth in Section 1(d).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>5.</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><b>Confidentiality and Restrictive Covenants Agreement</b></u><b>. </b>As a condition of, and simultaneous with, entering into this Agreement, the Consultant agrees to the terms of the Consultant Confidentiality and Restrictive Covenants Agreement attached hereto as Exhibit A (the &#8220;<u>Confidentiality Agreement</u>&#8221;).&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;"><b>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Successors</u>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement is personal to the Consultant and without the prior written consent of the Company shall not be assignable by the Consultant other than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Consultant&#8217;s legal representatives.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. The Consultant agrees that the Company (without any further consent of the Consultant), may assign this Agreement to any of its respective directly or indirectly owned subsidiaries, parent entities or entities under common control with such parent entities, and in connection with such assignment, such subsidiary, parent entity or entity under common control with such parent entity shall expressly assume this Agreement; provided, however, that no such assignment shall release the Company from its obligations hereunder.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>. </b>This Agreement (including Schedule 1 and the Confidentiality Agreement attached hereto) constitutes the entire agreement among the parties hereto with respect to the subject matter of this Agreement and supersedes all prior agreements and understandings between the parties with respect to such subject matter. This Agreement does not modify or otherwise affect the Employment Agreement, which will remain in full force and effect in accordance with its terms.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. </b>All notices, requests, demands, claims and other communications hereunder will be in writing. Such notices, requests, demands, claims and other communications shall be sent to the recipient party at the address indicated below or to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"><u>To the Company</u>:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;">Proto Labs, Inc.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;">5540 Pioneer Creek Drive</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;">Maple Plain, MN 55359</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;">Attention: Board Chair</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"><u>To </u><u>the Consultant</u>:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The last known address on file with the Company.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Miscellaneous</u>.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be governed in all respects, including as to validity, interpretation and effect, by the internal laws of the State of Minnesota without giving effect to the choice or conflict of laws rules thereof to the extent that the application of the law of another jurisdiction would be required thereby.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties agree that any dispute concerning this Agreement is to be brought in the courts of the State of Minnesota and the Federal courts of the United States of America located in the District of Minnesota with respect to the interpretation and enforcement of the provisions of this Agreement. The Company and the Consultant hereby consent to and grant any such court jurisdiction over the person of such parties and over the subject matter of any such dispute.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that attorneys&#8217; fees or other costs are incurred to secure performance of any obligation under this Agreement, or to establish damages for the breach of any obligation, agreement or covenant under this Agreement, or to obtain any other appropriate relief under this Agreement, whether by way of prosecution or defense, the prevailing party shall be entitled to recover its reasonable attorneys&#8217; fees and costs and the costs, fees and expenses incurred to enforce or collect such judgment or award and any other relief granted allocable in the discretion of the court presiding over such proceeding.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for any rights that the Consultant or the Company may have in law or equity to immediately seek emergency or temporary injunctive and other equitable relief, in the event of any dispute between the Consultant and the Company relating to this Agreement, before proceeding with any legal claim or process, each party hereto hereby agrees to first notify the other party in writing of the existence and nature of the dispute and to enter into discussions in good faith to resolve such dispute. In the event that the Consultant and the Company are unable to resolve such dispute or agree to mediate such dispute within thirty (30) days after written notice of the dispute was first given, either party may proceed with such claim in any other manner permitted by law and in accordance with this Agreement. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When a reference is made to an Exhibit, Section or Schedule, such reference shall be to an Exhibit, Section or Schedule of or to this Agreement unless otherwise indicated. Whenever the words &#8220;include&#8221;, &#8220;includes&#8221; or &#8220;including&#8221; are used in this Agreement, they shall be deemed to be followed by the words &#8220;without limitation.&#8221; The word &#8220;or&#8221; is not exclusive. The word &#8220;Agreement,&#8221; means this Agreement as amended or supplemented, together with all Exhibits and Schedules attached or incorporated by reference, and the words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereto,&#8221; &#8220;hereunder&#8221; and other words of similar import shall refer to this Agreement.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any provision of this Agreement or the application of any such provision to any person or circumstance shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision hereof.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any of the provisions of this Agreement may be amended at any time by the mutual written agreement of the Company and Consultant. No failure or delay of any party to exercise any right or remedy given such party under this Agreement or otherwise available to such party or to insist upon strict compliance by any other party with its obligations hereunder, and no custom or practice of the parties in variance with the terms hereof, shall constitute a waiver of any party&#8217;s right to demand exact compliance with the terms hereof, unless such waiver is set forth in writing and executed by such party.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 63pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed in any number of counterparts, each of which when executed, shall be deemed to be an original and all of which together will be deemed to be one and the same instrument binding upon all of the parties hereto notwithstanding the fact that all parties are not signatory to the original or the same counterpart. For purposes of this Agreement, facsimile signatures and electronically delivered signatures shall be deemed originals.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:justify;text-indent:-36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*&nbsp; &nbsp;*&nbsp; &nbsp;*&nbsp; &nbsp;*&nbsp; &nbsp;*</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">IN WITNESS WHEREOF, the Company and the Consultant have executed and delivered this Agreement as of the Effective Date first above written.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">Proto Labs, Inc.</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>By:<u> /s/ John Way &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u> John Way &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; </u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Title:&nbsp; &nbsp; &nbsp; &nbsp;<u> Chief Financial Officer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>CONSULTANT</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><u>&nbsp;/s/ Victoria M. Holt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Victoria M. Holt</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:144pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:144pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Signature Page to Consulting Agreement</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:144pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><u><b>SCHEDULE 1</b></u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:72pt;margin-top:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:72pt;margin-top:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:72pt;margin-top:0pt;text-align:justify;"><u><b>NATURE OF SERVICES</b></u></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.5pt;margin-top:0pt;text-align:justify;">To transfer knowledge and expertise the Consultant gained as an employee and Chief Executive Officer of the Company, the Consultant will be accessible to and will provide information to answer questions of certain Company employees (anticipated to be the Company&#8217;s Chief Executive Officer (&#8220;CEO&#8221;) or the CEO&#8217;s direct reports) members of the Company&#8217;s Board of Directors. The Consultant also will assist with other services as reasonably requested by the Company&#8217;s CEO or the CEO&#8217;s designee(s) or any member of the Board of Directors, including but not limited to reviewing and completing corporate documents, assisting with litigation and threatened litigation, and providing such other services whereby the Company determines it can utilize the Consultant&#8217;s knowledge and expertise.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>prlb-20210129.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 2/4/2021 10:18:28 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:prlb="http://www.prlb.com/20210129" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.prlb.com/20210129">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prlb-20210129_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prlb-20210129_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prlb-20210129_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.prlb.com/20210129/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="prlb_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>prlb-20210129_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 2/4/2021 10:18:28 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.prlb.com/20210129/role/statement-document-and-entity-information" xlink:href="prlb-20210129.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.prlb.com/20210129/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>prlb-20210129_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 2/4/2021 10:18:28 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>prlb-20210129_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 2/4/2021 10:18:28 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.prlb.com/20210129/role/statement-document-and-entity-information" xlink:href="prlb-20210129.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.prlb.com/20210129/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>prlb20210203_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prlb-20210129.xsd" xlink:type="simple"/>
    <context id="d20218K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001443669</identifier>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20218K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20218K">0001443669</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20218K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20218K">2021-01-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20218K">PROTO LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20218K">MN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20218K">001-35435</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20218K">41-1939628</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20218K">5540 Pioneer Creek Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20218K">Maple Plain</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20218K">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20218K">55359</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20218K">763</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20218K">479-3680</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="d20218K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20218K">PRLB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20218K">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="d20218K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20218K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20218K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20218K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20218K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140259296727160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">PROTO LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jan. 29,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-35435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">41-1939628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5540 Pioneer Creek Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Maple Plain<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">55359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">479-3680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRLB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001443669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( #:+1%('04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ -HM$4GL[#LKO    *P(  !$
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M;',O+G)E;'-02P$"% ,4    "  VBT12.JJBYT !   \ @  #P
M    @ %8#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ -HM$4B0>FZ*M
M    ^ $  !H              ( !Q1   'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ -HM$4F60>9(9 0  SP,  !,
M ( !JA$  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]!(
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="prlb20210203_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prlb.com/20210129/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="prlb20210203_8k.htm">prlb20210203_8k.htm</File>
    <File>ex_224239.htm</File>
    <File>ex_224240.htm</File>
    <File>prlb-20210129.xsd</File>
    <File>prlb-20210129_def.xml</File>
    <File>prlb-20210129_lab.xml</File>
    <File>prlb-20210129_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "prlb20210203_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "prlb-20210129_def.xml"
     ]
    },
    "inline": {
     "local": [
      "prlb20210203_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prlb-20210129_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prlb-20210129_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "prlb-20210129.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "prlb",
   "nsuri": "http://www.prlb.com/20210129",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "prlb20210203_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.prlb.com/20210129/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "prlb20210203_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prlb.com/20210129/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-21-002024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-21-002024-xbrl.zip
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MYD:'X=9["+LE;^\^?%;NPXT6]=9Z$]<>P=[5^ P@KNM49R8TV9N%@;G%U6=
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M*G7<12#SR??""$NXS E:+6EF]QNVX-E_B6#<U_$E[/VY2&>7[9FV>Z;MQP>
M/RG3UM/QO@"F[5L/YDMDVIY^NV?:?N%,VZ=[INV>:?LAF+9//SC3]NE;,&UO
M%<'VZ0<FV#[]H 3;IQ^'8/OT$Q%LG^X)MON0Q#XDL0])W Z"[3:_9$^PW1-L
MMRWA+3@);M7.W1-LWQ/!EFB9MYG82H<MERC\?D]M_1SWZBYJZP\=B-HMH;4&
MI%1FF/$5/5QF!SYLB*G:(5,U%TI@<.$3EX2.&&J,36&Y7<'EPTVV#<ZG'>D(
MG/U>>>)FJ%4VMS=@<UZ742?<M2"PP'3#8+DL3\YY6-P><BP<J4W9BDG8>G1?
MP%1CV25LF ]!JJ<UZ)Q]1Q"\\+0\O<25H2B'T=/]]GM7WLVUPH?79<#LF2Q[
M)LM7QF2IZCV9Y?,ALYSO(+-(W;<S/YLQO06F\P>GPQ*DBK!$[XTX@Q(V*TVI
ML?3[ WN?S&I+U;FW8C#TA"JX0B>ZAVS[Y3EIH@;M&.K+IE?74B053O92-@V9
M3&R\89!T8E9Q6?WAH#?IT7<F)J!.C&@=C'AO_TU4;C95X336&5@)8I1G]C)+
M-H.<,17<!S6$QS\\;V+#_MW#PGM8^(N"A<5BWLFX>SOH]U-4LD-HZVLM91=@
MUK<WN/>VT5#RD.W!,SQ*)-:Z]X(3%XMG'WMS?\BX3HW,K+?>):0=4.#%X3:;
MN+8V1R_=">MI44RH%STAJVP?0;H5$202%L0HQEN66IP1ES@9OB-^_XU>FY"#
MWIV9]X]WNA)[A3:XH6PW87@?Z_H,8EV->9,=W+]>;,MO$+I:$323*Z4;1Z$L
MQ39M'TQ&F"/>[$-EMVQ37WXX*X5EIJU!N,TDNU1%IVV)$!=<>J= UT(7T_A.
MC"TN#/-A\<HJD(J9)FKI-M38WXO4'P-?OA369K#1)]JD>*[3K@4M-)'#7W35
MN%OKVIE?_8-_4BV72(NF>4C@4QN0*''-0/S[KR8JNI&:"_SN1+-LA"01KJ!%
MMWP[>RX&%^UHJUD2-EX3SB!\,4>G<::P1U'0#IG?(%1O3-/V;C)!G*I;+G<A
M=<@;5V0F80$5LE[)-GJCZPDF#_!<.4$+@?>@& J%(:HK/>U'5"/Y,PC.D@E)
M]X*C5TH/N]GSQ5>:08#4R^7V4&E?'H=1T%T!5=RL%*_^@''3JG8^Y'5"J-D9
MQ@]BEG&28GM^A$K+-12,ZOH^293*$9N)0>;(W6MFCMS,<'Q_N66A3C\Y_G[/
MI-U#IE\X9.I#:,^.KI6[F-J:8.U0@:?^1>+!)6-Q8<9^&[T<7N+Q4.A7JY(B
M<O921DM=0<4:\8(P/$O?3*M)1RI20KQJB1:MI-S0"=HR@W=OMT;+?W&]Y0^O
M)GN$R^<+9)DWAS^3$_,,L_M8+,Z&,&?O7L'AO9HV,CNX" ^-)H,)*E.6! R7
MO]'+E4"JZ(5QEC2)A1Q02^>B3?5,(Y81!]*'-ZZ%UVW:FFAXNLVZ%F]]G'>&
M,SKY\E%,WI1$;-34*[P;#WX8-\BY*S:ETCTH&9!J"D8"&&,<'Z2446BB6!]E
M?[,7UYG(2G3! T](8#L&=L $K#'DD2"/@"8"WE.-O&4HF9ZT<>S"' C/)J@Z
M&'X_"NZ.M4N5G,PM-\7&T6F*8]M;9U=ZPNGK%C2TS?0N(Y5.;AHC<68"Y1!5
MH S[@LF0IZ.#IR-PHD%OQ,+WJ^O-A?0F74 VI]L0BW6/M@)N /0-@R5H$UY6
MC%*B0)$@39R]KZ98'X'<@8:V3ZO>T#2#U.)SJ:L <^L%"*\R6L-A;FV #8L!
MR]! 0Z8= [_0"LX"V:+.I8.I0SA#H Q<.43'MX=1\@SA>=^0O9E^,)TQEXKA
M3,3!8O!B:DE0$8]ANW,3;(ZM@C*BAMD1D=N%,65. -[^O(XU,0P"2_\M5DYJ
M7;CYGUIV:"Q\SV3IG@LL))V@"4Z*833F;0J AAS2EUA<#LY&"=PA0/H3^ /%
MXWJ3U"_0F*J/*+R)N,CAMA%;I8>N,$ZL)0V2%RW/]3MB4VVE&",W'K/4(M?G
MXHAS,I^.W&NP;>N'C%6A@DWK7K,AM3^DI-E H-21;>+<;'_^46XY%\BD)E!G
MV'=.JVX,MI-I^<IC>_+A9!^<C-@'#U,J!]ULPOBCB)KTS"K96<]PBQ4.*$JZ
MB=6K&3YA<RL-?/\L4OQ9 4([C7'G$1_/=#JZ'-!>3FJT37JIH/#U:U0 '>C3
M5^ZDS4Z.\.'#DX/QZ.#;T>'!?<FL#3]_,"*M(BFW=T?QQ! ?Q_'3&<]T4+ J
MFNKCCG/7(&$PEWMS-3)7?[@>X>_T^^,?LY\P[9V--&$^RW%XZ4I,#!AA?.P1
M?.7O'G;WDMNDA.B.:(MWD<I+IG7C43LTI7![3A:=9P@T=F\&R(GUA ))HK%%
M%1U0U/$H=<4[@F.+Q93@.3RPS!)W/*$W]%LGG@\>/)#H"M.-[>"=?:&-S,I#
M.CY R6*I)SZ49UW! 294J/X;U3C'36I:R"YBU(N[ZX]AQ%V])4H_V[DV@V,Z
M&*O$7H;#I-=3313'8P>#OB*/DTX^A ?5'_AOT+X5Z7Q&,B-=/]/0/D;6^&H"
M[%U13:@<#-[#3A\$]'/HDJ4\WV1->'Y<8)>.TU4;@:4YX8Y2%O,0FQPKT'.Y
M+ULM2DS.=?C83F".QV:4F<-E8@JJ\M7@,/IKXN9>/.T;33ZCDS%"ZB#%)$KY
MPY%#*.EZ;@Q<UX9T.*+QI5T=_&!F:JRO47"5CIY]:(/\+$%LQF6!Q50% 7'8
MFRU8;-D2?#]B5]$E]0FG]8Q?KA)^*\H9\F/CP=JQX-471=?8B./8\.Q3E90X
M&!F.@3(C,&@D)_?1 (!9LMP*!V#BO-00MQW,,)]FP5AH;:E^AS/$-=<X7WE8
M&+9"7;TQ2WD#CDC7C-OX3>*E'INLT76B);>MYJ%%[SSD89.)HS44KH;5(KZ'
MQ2P,M*5X][,.VFT65D6&8Y=0%:'QCF)M\:7&IFCT9ROP6'"N*;TKB&%P,92>
M,&P2^&&4<$P,F *S 9IV9P?([TQ%J+#!2"PPYHXZ2K4;1(/VJZ/V89LA;_I.
MD(^P7<1D'!'OR(/_ C/308ELG=7 O;7T1N;^29I(K=DGFX!K459%-4?&@\PY
M0P+VD ];Y>"3^,8%:\8$B5 X,($?((9#;>9S7?.Y@]Z=5WIV<]/@J*/1>QF[
MDI$\XC,[E8SWCFF+#!&58,1Z(CJ>H<@=N6/G4:XXF/ISA:>2)\_&J<2EYWL/
M'$WJG4+-!^9(B\()QDNV#H@VG6]E"S),[W1O"%,G^](PDA S6B&'',B3QV50
M4TM8Y:2R=^@\0I%N_<3N,J,-$*/8$EFB'C5Y P/9+E33?J2(USZ^M8]O?>SX
MUGO-:0G]P[LN7_W['>[A*XR5&[2;T%J[D*R=T.*S6)'W[ZS."5/T-%H'R MI
M>UE_O=\*R#U!&S*7+"(J[SA52S6'UXU]EBOS><:US24B9!Y=S\9A\U';DCSI
MV!=TO)+FDAX1TX.=&.KH3%U6-1L7=K2,$HIU2S;=Y(^RNH)1S@447L+.6+ON
MHITA&8M4V T1PI9N--'3M<O;]6-@KIV,(1$@% -7"E-BK];T#NDQ8NW9U#03
MC*Z@1@4#<&U3),'ZJ<F7H3OAK+YVM1')T?Q'5YMF:ISMTD?OK#X^.17G_A]=
M.9%$NL+H663"V46GA%.V!; ?EZ:RUM0U1GQ;X9R/L#D?[-B<9]#C&J7M!VUW
MZ'/>!GS'#?*A9*V1B43+'0;M@B<Y[@=:DV[#66>IM<T1)QT3)FT1"072@FY4
MUR9$59#:&V2<$R0B*8%:_]'TA,AY.ZDW5?03M_%(.A'OH*TEE#(00F4*'#KO
M'(_5!*K*:IS0D;,3/4.FOD,NX1 \[+<I8 D_:1U^[7+I90\B.7]L6KYZ2 S*
MEI*"'%%+;BF"[Z45F0AA,SNT6A;0K@LS_&#AQ<=E8#?HDQMS+]>3/'[6AKR3
M^3>6'8#FW.TM-_$1-N/)\:[=V& Z&JDLVHJO>R=;F+VNZ%EVYRFQ /4VBP)*
M48[B(O@A2RHJ7]QE*"B(YH"RYEB:CV94_O&<JN.N LS6Y[^M\ZBQH)$ 'N/^
M9:04"CTG.6.$JQ?^#LYS AO',).BVY/GNSN*0#CM5336?QAW#<;=&PLPH7-+
MAXZ'F8)A9$M=SVG2)O[*5!LF'<7H5/BS1O- 6JS5,=.U@^ZB,M7T(0\/YD*W
MY.9,U,K@O6?D!@W+(*?HJ7S=(HZ:9[0W'1&:@+:%@2V?S'0D%PQU,2JGDF&7
M,%"&+_\%]-$Y'>6\JU/"I]^LQ(EM)M5*)R^%4TZ2DY!(@E)K)6K8=:;-]D4V
M2H$P#?=LPZ5JGBEMO6L:0)(3^9;=/T"MJ=\HZ('.!\B7[%DP4A9F;%Q98C::
MZ!R=*XPNXA,(^Y"LN.K,EL<P0:Q'V*E-!U]>XC]$U$T8:*G2UU7TJ"U38XLE
M%X7%_NTK:]N5K" FB^,N;V!$?ZCE2%)41Z)'"2CCY \A#T$?A3ODP_,1Y===
M7NKU#%'@*(K-RZZGH=::AG0/HOTRI!3 TL&.385Y&;]A#1>].&6JDJO@U6&^
M6Q]R]TR)@Q9D5>!!.[.>8ATBWO@@9O51N4L<*9YUEA]%9H74CK'DBUJ#I8)[
M3^$B-Y&^IR==LV[NL<79C*Z;QM;[+9#W0W/N)$+F\A98"7M\9H_/? GXS,G)
M#JN3;T3A$ENT)5]I%X>Q=N@ OF"*3.:JQFP"&X0[:AT/45 (&X<,#_3OVC;(
MNB;-,.2@VJKZFYB 3>7L54E39-992F_"MZ#V*,7F$N:1TWV[4KH:I'"(S@K.
M%N@BW22P"RX28S>,H1%)# \%JY,I#8Q'YSHB71MT2"!\?(C\<'K*KII[CA>R
M\M?S2O_<*W'VUQ+GIU89$4J<*E)/IZT[X<^ZA<3$)GG#-2;2=X)RV$HB BB2
MJ4PFQ(9=^:9><H:]7'%O^"M+?LC8J:=>\<T:_JRS/A)][@V0&_44PVQKAL2"
M*X,^]:GTR;3(Z0XM JX,6HZL,,YX#5S].?;.D/;7E;(3@MAE50<:@+?"'.R#
MDD1#:@T$D(.E(D2FC;?-@ANB.XQI44L@JYXC8RT:Q(=!H@H6D(FNY6XO_"P[
M #77U:4C?TB 64]';)MS<4.$>4HR*:7YM;6A\\R2Q=&0K-4RSV9JTH "PP@]
M>HY+TUA!PV?>6*UF-:WXW=X65M-IC9P>,B-MG3#)^W-?J0"?\7QOV0"V:52S
MY@\M:[2U*M;G+M:#9#.1:2PP%^5"?J0[U1)=>5E7T)6?U!B:>UY./D$"GG3D
MWKUOC[.7(),:>40U@J'/:I#J3]:AGQ6XTYAUA*#&S[]D]^[=O??@D_7F# $(
MU%T/);44'%-3?[V;QWE_GV[K?.)Y>%6-X=0 :9A66^7@2YZ#U\3H 6,>HYBE
M/8F0ZS,SQ? ROJ_"AOKF"9M#Z)"P 4)G<NY+!7'2?-E[:KPFXR,?H$W\-:?!
M26Y'90E='>*WKOB0SQU:512*OLY+MYDQ57P]K9H@/=,_1R#5[C=<TQC*Q12J
M:H\[V5=MZDK/F$H7=!ZT]E7(X09;_NX.6_X'%"F0H#/F>;)-__M"TX>P- 0:
M!S2+(9V88[;)]&3B*7!(2K $ME<UG2;LT,DBQ6G&0N1&4B=]/I->*ELV(;!\
M/23@V 2.2L?O;BM;_L%&:JR![$,O(?;J;6D.LG!!=4__7(*/[W*?W?C9N;T%
MLK9',_=HYA>!9GZ[0W>]1O+[CF<<J!E&=6W%%5\TU)))$Q5= J",5-%;I:4T
M<33.IXTSY=6C(ZIK%U5-16+9'*"^(G 8YEOV*O4+;<>GS1^!P4XA?<L90_JT
M':-KL7]C@YV,B&;;2T)E*CS7ZD[$2[?>$-&W#QGZQ1)''#VL9;;<?/ ,A(6I
M["_E$H!H"IIX#IH\#E-*9CG>-X-YBK;L6I#SZKI4%-(3HK)O(OH'LY0'&3]P
M8BS'L%;"P)-)=[P%Q[T/J\K3? 9<H7B8VS+BWG4-XFR(::4YGCOO%!'$M6,.
MF@G=I]U+RY:[1I /T+_-)ZC%RZE%\1)252E7'EC*.$1Y#2??6E1=9FX+_!ZA
MUT3+(A&*)A/- *EZC_\$E=\TA]W*E3D;9)SW6:+X21[4BY(H;3ZP>_IY11AU
M+BLO>@S;TWL5&< < XA>'J4X\A13#E9L=* LK+3EQO2G)7%/>=X+J'AV*+@0
MAR'[KI>_NWD7^JSKX;HX*PT&*N0X:F%8$K4.+WI8^?MPA.!'5(1>1G&M@_&U
MU[LO)HMO3):4/6)T*/L>+AKIV5##U\IH+#?A-:57P(\*5QJ,(E*<X7]R[\^]
MFX-Q(J)6/1&/WTUX-[%3@M:2%_3:9-:KRI64@''/7)D)5UI"!A40G2A?C"^>
ML2FX;LQJ#DO(3*YK7*ALFC#L8V-QP9WKTZI Y<'7J_O[T8,L1G^M^NG!?'1P
M@I5$XOO3-Q9 5$$.,;2=2/MN7/.#_.^#9]M3P#]83L@GLZKN7:\DT7/XX;(D
MMP]G#G]SE)UQ[BJ7] 9! H&(;_1(TX DR!O^.*;]#-1!_S!9JA8$N6&)I5^E
M+I+:<L[E"=W@*N(&)T,DWR:>@SR;PIDR::LZJ(&-50?A >T_*XP-S/IJN3XR
M!B]J11A)ESNTPO^L/_B;&54)'GYL)T53X6_,6A^2#84]G1-(1+]W'GENDU)M
M2WYPJPH^,VSF"@/84!ED^&Y0(.PKVVWW=_@G/S(>!Q+]DY1[_+L&D4R2@DUC
M(4+Z$6\S_(DW?3:44&'K6(H'M8*I_6S ;FRJ5CE"YEQHAJR=+?MV44G=47C-
M#%;:985$ ?2Z*VSM6C+E_&T:O;QBVQ=L.TH@"2ZB2_<S3J[AK!IGOTQ-LT),
M*4IJ3D^?9;\+E/G,,%\6M@32[>'3OVEXXXI(B'#V@>[P4V6G6P@OT0#PNTM-
M"H6!HUL !GTRP?]NA^!?@.X%2RJ@0PXE/G=$95BC25$U7?@+_VV2QLQ?7]@L
M+;[WU'TK)6IQ"OK?./.=2B#B(:$LXY;[3&9+<-?JE&51')'V2HLE*I+J^/7V
M0@=RW/H@HY2SZU:44JL#OV?8^,8*!IA/8J%;)A5Y$D6>O&^5KINP*;1\RC[*
M'ILG \>!R][3=@/C;H$C%W24#U/?<W()6?L'I;_ZYTV4_QLA#GSOH,4&N/ZO
M\JOCE)J?!<(?2?OQJ(1*\C5OO^^E5,].*D_VNT+\W=XCS&7^6-E+NL\6KRY%
MQ;G"]J9.Z*FF-V%EEF-O23U"P [X*FM'CK]:X)VE3-8*BW!1XS7#.:C#N8""
M31B0;R-BF'1166L/WRS/=245V8["&]33J<WM9]\:1+KD*X3MII%?)";+CCXF
MJ 7EB91]>Q7<1!BWX6[Y9@HB@B"-0_WP^ T/2M6+SW ';H'H[\,0^S#$%Q&&
MV)582T:BKE&!-4F[W:9D<M13 &7_F]P?:70:6XHKT6YA@RT\(5M-K=9T3UL'
M#32A3>T)&Q_H:H76NH%9H!C&D/K;5G.V(+P&"[07XDO6YJ#7&_K=%Y]Z+;H%
M!,(\^3]\D6!'%V;-+6NS^;]H(7V\CNQU[5[7?KD%]*WZQ7:BOERJVBAXHEF"
M9CJ<J%7#6OIYF?UN6DH(_IV9&%PP#G_T)(\8T62J.F7<KYCA<)(+4L/H7A B
M*96QL*ZLM3=OJ\;[W)2M?4OP"2FIX-^LHNY_?W3OSX^"OJ:1/Q"'UW^[R,Y?
M_/SR[)?_?IBQ)'P)\[5I"VP%0K'X_X!VOGU&/D:W/B:7]9LG3]>/NR?9G>9.
M]A_5 G0%F&02O'O+/R*2R4?^PU%;N@]O<'S8U=JT]4].^WL_>&++SN^>?)H5
MN85_W"[I^'QT["Y=>O%?%^>_O7[^]XN'7\ZY<EL7%_8SJNPP]^)6[*W/06-_
M_(25S4[I3V>_OC[T;ES2S7RO[J/UGN OXVJZADE?M,OBR?\'4$L#!!0    (
M #:+1%+X46<U"QH  -V.   -    97A?,C(T,C0P+FAT;>T]:W?;-K*?VU^!
MF]WMVO?(CNTDW=9V?8[C*&GN)DZ.[6P_W@.1D(2&(E6 M*W[Z^\\ !!\2')>
MCM,Z'R*+(H'!8-XS&!Y.RUEV=#A5,CWZ_KO#4I>9.E+7_[NW]WCO\<XV_'KX
MD"_"K_^UM25>J%P96:I4C!;B8EKEJ3+/BID2;PM3RDQLB;V'CQ_N[>SMBMV=
M_=V?]Q_])-Z^%EM;1X<S54J13*6QJOSE056.MWYZX*[F<J9^>3 NS$R66ZDJ
M55+J(G\@DB(O50YWERI3\VF1JU_RXL'1]X</&>+#49$NA"T7&3V>EUMC.=/9
M8E_\\$=5E <7>J:L.%57XJR8R9PO#@1='@BKC!X?"'K.ZO]3^P#RO#P0<YFF
M.I_LBQV=BYWM79T?B*0RMC#[0E9E<8 0S/VT,VDF.M\:%659S."9 U&JZW)+
M9GJ2[PNC)U,8TMU4%G.ZXS.!"NC#*[T(^&=KP'^N'VMT-+R>ZI$NX<+VWN'#
MT='A0[P+/N9'W]]XR9D:?R,K_B$?V?G!DD7&8Z\;NAZ9*(C7OH]_1HA)@)*5
M >(YK!#7)V].S]^]NGAY^D(<OS@;#E\/3R\8Y]5MPC(*6!A]^6E_KVRIQPN8
M]V*JK3@I<EME)?":.)X8I68 E=@H\:<?_O;3WM[. : J_(*(H<N[!YL";IG)
M5 F9IX+6 A))YV6!8@FOC51YI50NWIH"+KZ2(P#T99YL#X04KW6>*UN@-"K,
MO !Q!L(&YU71M"?%;"[S13SI@$;^CT[*PF@89EO\6F0ECFB4U2D"7XP%#G->
M@HC$+_54G>%IZ;*YK(%0XS$*OTM8F<4!GJN1J:19B,<#05*U-<XPW/\,IHS'
MVK[%W?0D=(M4>S8\>7EQ_.I\'=U^L%AHB:[H0I!W<.W6UNR13)=TCE2V_^A'
M@@"P\-NOP[/A\?D L4"45],5LHB:S;-BP<J:?R6B1MK2)?#?5*NQ&%ZKI"(2
M>C,>ZT29/R'E?#06D9MV_W7@44D2ZDJ7TP8Z =-PJT[TG"PC$#AHN.B\4G";
M*:K)M.;CO9^8D0<WF,BH4AN6BBF,/."9;95,X[O<7"A%4?XID(-")B#:4IDG
MJH866&=FO80ZAD=3@!4EVIFR)0%>4\*P'KZ6S"W1VB HN!Z17D,BLR [KB:P
M!V(75[_[L]C0>9)5:&8);W0<XXBPY()1XV1<'R2W+^)ZZ.:N4FZ](2UY,)6H
M51"'^),L0?!E67&%6]!#AA'MC4TQ6T7_ R )@#S'D4"1OI8&"'2W2>8,U97.
M,B".B9RH-G1 *'-37((:18+V9@$@ZA)$DL6?XX'F8(Y7[K$6;0,S!D+Y:TNR
MM#(D%&I$X]>W,%>1B@U@RU2-=8[:00$=;+8E$N\64TT">V"=8!N3J:-E-L =
MFQL-'IQQ%&?0)K,J >H!YF>'#HTK)W4"P>#-FE14"J:3D:.,33G-8F4$$@F%
M!X@#6]K6T^YA*RSXDFI:9.""6D<_Z#E^3AAA5+BS,DB4Q5PY4Y$8HH$H8 @
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MB2(1V;;;64Z"GR$Q6M%.9U& @YZ'7]C0I2&[:%F9A7)N'&]<.\ ;1+Z<SS/
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MTS9L)E"L.V!)C_ZIB92"I7T46AU=-+((2(6?_RCI30J2/Z7^^"L U6X!=<?
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MP/7/8U@CI'11#AW3B2-:D:UE/ <:L,N \O1"2R'#%R-6H=-3/J40MI;RV8^
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M2P$"% ,4    "  VBT12^%%G-0L:  #=C@  #0              @ %A.P
M97A?,C(T,C0P+FAT;5!+ 0(4 Q0    ( #:+1%*\%%1!A0,  )(.   1
M          "  9=5  !P<FQB+3(P,C$P,3(Y+GAS9%!+ 0(4 Q0    ( #:+
M1%+V&9+;W@0  (<M   5              "  4M9  !P<FQB+3(P,C$P,3(Y
M7V1E9BYX;6Q02P$"% ,4    "  VBT12:3'#V_H%  #?/   %0
M    @ %<7@  <')L8BTR,#(Q,#$R.5]L86(N>&UL4$L! A0#%     @ -HM$
M4E.EB7]X!   &2X  !4              ( !B60  '!R;&(M,C R,3 Q,CE?
M<')E+GAM;%!+ 0(4 Q0    ( #:+1%)U* 'X41P  #._   3
M  "  31I  !P<FQB,C R,3 R,#-?.&LN:'1M4$L%!@     '  < OP$  +:%
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
